These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 15368443

  • 21. Yo jyo hen shi ko, a novel Chinese herbal, prevents nonalcoholic steatohepatitis in ob/ob mice fed a high fat or methionine-choline-deficient diet.
    de Lima VM, de Oliveira CP, Sawada LY, Barbeiro HV, de Mello ES, Soriano FG, Alves VA, Caldwell SH, Carrilho FJ.
    Liver Int; 2007 Mar; 27(2):227-34. PubMed ID: 17311618
    [Abstract] [Full Text] [Related]

  • 22. Role of adipocytokines in hepatic fibrogenesis.
    Ikejima K, Okumura K, Kon K, Takei Y, Sato N.
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S87-92. PubMed ID: 17567476
    [Abstract] [Full Text] [Related]

  • 23. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.
    Nakano H, Nagasaki H, Barama A, Boudjema K, Jaeck D, Kumada K, Tatsuno M, Baek Y, Kitamura N, Suzuki T, Yamaguchi M.
    Hepatology; 1997 Sep; 26(3):670-8. PubMed ID: 9303498
    [Abstract] [Full Text] [Related]

  • 24. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
    Luo XY, Takahara T, Kawai K, Fujino M, Sugiyama T, Tsuneyama K, Tsukada K, Nakae S, Zhong L, Li XK.
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
    [Abstract] [Full Text] [Related]

  • 25. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM.
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [Abstract] [Full Text] [Related]

  • 26. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.
    Ip E, Farrell G, Hall P, Robertson G, Leclercq I.
    Hepatology; 2004 May; 39(5):1286-96. PubMed ID: 15122757
    [Abstract] [Full Text] [Related]

  • 27. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
    Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Zhao JM, Yu J.
    Scand J Gastroenterol; 2009 May; 44(3):358-65. PubMed ID: 18991162
    [Abstract] [Full Text] [Related]

  • 28. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.
    Veteläinen R, van Vliet A, van Gulik TM.
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1526-33. PubMed ID: 17716355
    [Abstract] [Full Text] [Related]

  • 29. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S, Wang J, Liu Q, Harnish DC.
    J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
    [Abstract] [Full Text] [Related]

  • 30. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ, Yeh MM, Van Rooyen DM, Teoh NC, Brooling J, Hou JY, Williams J, Clyne M, Nolan CJ, Farrell GC.
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [Abstract] [Full Text] [Related]

  • 31. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S, Hoos L, Cook J, Tetzloff G, Davis H, van Heek M, Hwa JJ.
    Eur J Pharmacol; 2008 Apr 14; 584(1):118-24. PubMed ID: 18329014
    [Abstract] [Full Text] [Related]

  • 32. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
    Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G.
    Transl Res; 2012 Jun 14; 159(6):477-86. PubMed ID: 22633099
    [Abstract] [Full Text] [Related]

  • 33. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.
    Itagaki H, Shimizu K, Morikawa S, Ogawa K, Ezaki T.
    Int J Clin Exp Pathol; 2013 Jun 14; 6(12):2683-96. PubMed ID: 24294355
    [Abstract] [Full Text] [Related]

  • 34. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium.
    Sahai A, Pan X, Paul R, Malladi P, Kohli R, Whitington PF.
    Am J Physiol Gastrointest Liver Physiol; 2006 Jul 14; 291(1):G55-62. PubMed ID: 16439472
    [Abstract] [Full Text] [Related]

  • 35. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan 14; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]

  • 36. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
    Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Ando H, Yokoyama M, Honda M, Zen Y, Nakanuma Y, Miyamoto K, Kaneko S.
    Hepatology; 2007 Nov 14; 46(5):1392-403. PubMed ID: 17929294
    [Abstract] [Full Text] [Related]

  • 37. Dietary steatotic liver attenuates acetaminophen hepatotoxicity in mice.
    Ito Y, Abril ER, Bethea NW, McCuskey MK, McCuskey RS.
    Microcirculation; 2006 Jan 14; 13(1):19-27. PubMed ID: 16393943
    [Abstract] [Full Text] [Related]

  • 38. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
    Nan YM, Han F, Kong LB, Zhao SX, Wang RQ, Wu WJ, Yu J.
    Scand J Gastroenterol; 2011 Mar 14; 46(3):358-69. PubMed ID: 20969493
    [Abstract] [Full Text] [Related]

  • 39. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
    Jung YA, Choi YK, Jung GS, Seo HY, Kim HS, Jang BK, Kim JG, Lee IK, Kim MK, Park KG.
    Diabetes Res Clin Pract; 2014 Jul 14; 105(1):47-57. PubMed ID: 24842243
    [Abstract] [Full Text] [Related]

  • 40. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
    Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I.
    Hepatology; 2003 Jul 14; 38(1):123-32. PubMed ID: 12829994
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.